Pfizer (PFE)

Financing Cash Flow

-$3.66B

Quarterly · Period ending: · USD

PFE logo

PFE Financing Cash Flow

Latest reported-$3.66B
PFE Quarterly Cash from Financing (-$649.60M → -$3.66B)
High-resolution chart · PNG

PFE financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-3,663,000,000
-2,856,000,000
596,000,000
-2,476,000,000
-3,196,000,000
-5,227,000,000
-5,114,000,000
-4,636,000,000
-2,459,000,000
-4,931,000,000
5,442,000,000
-3,779,000,000
27,174,000,000
-2,771,000,000
-5,015,000,000
-5,761,000,000
2,520,000,000
-6,578,000,000
-3,351,000,000
-1,101,000,000
-2,557,000,000
-2,807,000,000
-13,787,000,000
-2,821,000,000
9,159,000,000
-2,200,000,000
-2,440,000,000
3,273,000,000
-851,000,000
-8,467,000,000
-6,407,000,000
-1,406,000,000
-1,908,000,000
-10,720,000,000
-3,385,000,000
-1,728,000,000
-3,001,000,000
-4,921,000,000
-2,228,000,000
-1,624,000,000
1,945,000,000
-7,014,000,000
-1,109,000,000
-267,000,000
-1,875,000,000
-6,982,000,000
-2,926,000,000
-2,887,000,000
-2,040,000,000
-2,133,000,000
-5,744,000,000
-5,631,000,000
-4,034,000,000
434,000,000
-6,233,000,000
-3,291,000,000
-2,968,000,000
-3,507,000,000
-6,250,000,000
-4,035,000,000
-3,918,000,000
-6,404,000,000
-1,079,000,000
-2,523,000,000
-4,361,000,000
-3,211,000,000
-2,734,000,000
-1,828,000,000
9,408,000,000
9,635,000,000
-2,253,000,000
-2,378,000,000
-2,777,000,000
848,000,000
-200,000,000
-4,252,000,000
-3,310,000,000
-4,848,000,000
-4,254,000,000
-5,103,000,000
-4,977,000,000
-8,766,000,000
4,326,000,000
-1,862,000,000
-10,868,000,000
-818,000,000
-3,349,000,000
-3,996,000,000
-867,000,000
1,583,000,000
-5,385,000,000
-3,556,000,000
-7,716,000,000
-252,000,000
-3,044,000,000
-939,000,000
-806,000,000
-210,000,000
-1,282,000,000
-549,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.